takao orii - My portal

Profile Information

Affiliation: (senior pharmacist / 臨床教授), 薬剤部, NTT東日本関東病院・東京医療保健大学大学院

Researcher number: 50231246
J-GLOBAL ID: 202001013280569110
researchmap Member ID: R000005116

Papers

Does Diarrhea Influence Plasma Voriconazole Concentration?

Hirokazu Nakayama, Kensuke Usuki, Kazuhiko Hanada, Takao Orii, Toshiaki Kato

Therapeutic drug monitoring, 42(2) 341-344, Apr, 2020
Establishment of the MID-NET® medical information database network as a reliable and valuable database for drug safety assessments in Japan.

Mitsune Yamaguchi, Satomi Inomata, Sayoko Harada, Yu Matsuzaki, Maiko Kawaguchi, Mayuko Ujibe, Mari Kishiba, Yoshiaki Fujimura, Michio Kimura, Koichiro Murata …

Pharmacoepidemiology and drug safety, 28(10) 1395-1404, Oct, 2019
The utilization and challenges of Japan's MID-NET® medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies.

Kaori Yamada, Maori Itoh, Yoshiaki Fujimura, Michio Kimura, Koichiro Murata, Naoki Nakashima, Masaharu Nakayama, Kazuhiko Ohe, Takao Orii, Eizaburo Sueoka …

Pharmacoepidemiology and drug safety, 28(5) 601-608, May, 2019
Reduced Clearance of Phenobarbital in Advanced Cancer Patients near the End of Life.

Hirokazu Nakayama, Hirotoshi Echizen, Ryuichi Ogawa, Takao Orii, Toshiaki Kato

European journal of drug metabolism and pharmacokinetics, 44(1) 77-82, Feb, 2019
[Current Status and Issues of Electronic Information Provision for Risk Minimization: Coordination between Electronic Medicine Notebook and Patient Drug Information].

Takao Orii

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 138(3) 325-329, 2018
Induration at Injection or Infusion Site May Reduce Bioavailability of Parenteral Phenobarbital Administration.

Hirokazu Nakayama, Hirotoshi Echizen, Ryuichi Ogawa, Atsuya Akabane, Toshiaki Kato, Takao Orii

Therapeutic drug monitoring, 39(3) 297-302, Jun, 2017
Eculizumab Dosing Intervals Longer than 17 Days May Be Associated with Greater Risk of Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Hirokazu Nakayama, Kensuke Usuki, Hirotoshi Echizen, Ryuichi Ogawa, Takao Orii

Biological & pharmaceutical bulletin, 39(2) 285-8, 2016
[Academic detailing--evidence-based approach for the proper use of medicines].

Michiko Yamamoto, Takao Orii

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 134(3) 349-50, 2014
A prospective stratified case-cohort study on statins and multiple adverse events in Japan.

Nobuhiro Ooba, Tsugumichi Sato, Akira Wakana, Takao Orii, Masaki Kitamura, Akira Kokan, Hideaki Kurata, Yoshihiro Shimodozono, Kenichi Matsui, Hiroshi Yoshida …

PloS one, 9(5) e96919, 2014
Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information.

Chia-Hsien Chang, Makiko Kusama, Shunsuke Ono, Yuichi Sugiyama, Takao Orii, Manabu Akazawa

BMJ open, 3(4), 2013
[Safety of Pharmaceuticals and risk communication].

Hiroki Sugimori, Takao Orii

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 132(5) 531-531, 2012
Urinary lipocalin-type prostaglandin D synthase: a potential marker for early gentamicin-induced renal damage?

Hirokazu Nakayama, Hirotoshi Echizen, Tomoko Gomi, Yuko Shibuya, Yoshitsugu Nakamura, Kiyoharu Nakano, Hiroyuki Arashi, Tsutomu Itai, Satoshi Ohnishi, Masayo Tanaka …

Therapeutic drug monitoring, 31(1) 126-30, Feb, 2009
Relation between drug-induced taste disorder and chelating behavior with zinc ion; statistical approach to the drug-induced taste disorder, part II.

Takashi Fukasawa, Takao Orii, Masayo Tanaka, Noriko Suzuki, Yasushi Kanzaki

Chemical & pharmaceutical bulletin, 56(8) 1177-80, Aug, 2008
Reduced vancomycin clearance despite unchanged creatinine clearance in patients treated with vancomycin for longer than 4 weeks.

Hirokazu Nakayama, Hirotoshi Echizen, Masayo Tanaka, Mika Sato, Takao Orii

Therapeutic drug monitoring, 30(1) 103-7, Feb, 2008
Statistical approach to drug-induced taste disorders based on zinc chelating ability.

Takashi Fukasawa, Takao Orii, Masayo Tanaka, Seiji Yano, Noriko Suzuki, Yasushi Kanzaki

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 125(4) 377-87, Apr, 2005
Clinical estimation of vancomycin measurement method on hemodialysis patient.

Masayo Tanaka, Takao Orii, Tomoko Gomi, Hiroyoshi Kobayashi, Motoko Kanke, Shuichi Hirono

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 122(4) 269-75, Apr, 2002

Misc.

668

韓国病院薬剤師の活動-未来への道しるべ-

KIM Jung Tae, 平田寿美子, 折井孝男

日本病院薬剤師会雑誌, 59(10), 2023
Reflections on the Provision of Drug Information: A Guide to the Future of Drug Information

折井孝男

薬学図書館, 68(2), 2023
Construction of Protocol-Based Pharmacotherapy Management (PBPM) Using an Electronic Medical Record Interlocking Support System to Prevent Hepatitis B Virus Reactivation Induced by Cancer Chemotherapy

流石智恵子, 石橋正祥, 折井孝男, 梅谷直亨

医療薬学, 48(1), 2022
より安全な麻薬管理体制の構築に向けた取り組み-バーコードの利活用-

鈴木良, 鈴木良, 高瀬園子, 山口智史, 杉田匡聡, 折井孝男

日本医療マネジメント学会雑誌, 23(Supplement), 2022
Transition to New-format Drug Package Inserts: Comparison of Brand Name and Generic Drugs

折井孝男, 田代朋子, 熊澤薫

日本薬学会年会要旨集(Web), 142nd, 2022
感覚器・皮膚の病気とくすり B 耳鼻咽喉疾患めまい(動揺病,メニエール病)

柿木章伸, 折井孝男, 流石智恵子

薬局, 72(4), 2021
感覚器・皮膚の病気とくすり C 皮膚疾患褥瘡

折井孝男, 池田夏海, 門野岳史

薬局, 72(4), 2021
バーコードの利活用は医薬品のインシデントを減らせるか-注射剤のバーコード利活用-

鈴木良, 鈴木良, 杉田匡聡, 高瀬園子, 山口智史, 折井孝男

日本医療マネジメント学会雑誌, 22(Supplement (CD-ROM)), 2021
Survey of the current changing situation of drug package inserts to new format

折井孝男, 田代朋子, 熊澤薫

日本薬学会年会要旨集(Web), 141st, 2021
添付文書電子化と安全管理への貢献医薬品添付文書の電子化がもたらすもの添付文書の電子化による医療安全への貢献と展開-実効性検証とインフラ整備の在り方

折井孝男

月刊新医療, 48(12), 2021
Safety management of pharmaceutical products by utilizing standard barcode (GS1)

鈴木良, 鈴木良, 山口智史, 折井孝男, 折井孝男, 杉田匡聡, 加藤敏明

医療情報学連合大会論文集(CD-ROM), 41st, 2021
Strategies to provide drug information

折井孝男

医療情報学連合大会論文集(CD-ROM), 41st, 2021
医療機関における医療安全および業務効率化に資する医薬品・医療機器のトレーサビリティ確立の方策

美代賢吾, 稲場彩紀, 植村康一, 大原信, 折井孝男, 笠松眞吾, 近藤克幸, 高橋弘充, 武田理宏, 藤田英雄 …

医療情報学連合大会論文集(CD-ROM), 41st, 2021
がん化学療法によるB型肝炎再活性化予防に対するシステムの構築と活用のためのPBPM

流石智恵子, 石橋正祥, 小暮宗介, 原澤秀樹, 折井孝男, 梅谷直亨

日本医療薬学会年会講演要旨集(Web), 31, 2021
電子お薬手帳における医薬品情報の活用に関する研究-電子化される新様式添付文書情報との連携-

折井孝男, 田代朋子, 下村百合子

日本医療薬学会年会講演要旨集(Web), 31, 2021
医療安全と業務効率化を目指したバーコード利活用~インシデントレポートから振り返る~

鈴木良, 鈴木良, 折井孝男, 山口智史, 杉田匡聡, 加藤敏明

日本医療薬学会年会講演要旨集(Web), 31, 2021
皮膚疾患褥瘡

門野岳史, 石川夏海, 折井孝男

薬局, 71(4), 2020
耳鼻咽喉疾患めまい(動揺病,メニエール病)

柿木章伸, 流石智恵子, 折井孝男

薬局, 71(4), 2020
Review on changes in the environment surrounding electronic drug profile book: a perspective on future utilization

折井孝男, 田代朋子, 熊澤薫

日本薬学会年会要旨集(Web), 140th, 2020
薬局における医薬品安全管理責任者の課題と他施設連携の必要性に関する研究

駒崎俊剛, 折井孝男, 折井孝男, 末永由理, 本谷園子, 山元友子, 山元友子, 佐々木美奈子, 坂本すが, 宮崎久義

日本医療マネジメント学会雑誌, 20(Supplement), 2019

Research Projects

Quantitative evaluation of drug interactions and development of a prescription-supporting system for the avoidance of adverse effects

Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (A), Japan Society for the Promotion of Science, 1998 - 1999

IGA Tatsuji, ORII Takao, SATO Hitoshi, SAWADA Yasufumi, NAKANO Shigeyuki, HIGUCHI Shun